Keywords: vioxx, cleared, ra, usa, label, changes, reflect

Vioxx cleared for RA in USA, while label changes reflect VIGOR data

Article | 22 April 2002

Print This

Merck & Co's COX-2 inhibitor Vioxx (rofecoxib) has had its indicationsextended in the USA to include rheumatoid arthritis, in addition to ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in